Basics GRAIL, Inc. Common Stock IPO Date: June 25, 2024 Sector: Healthcare Industry: Diagnostics and Research Market Cap: $3.94B Activated in VL: True Average Daily Range Avg Daily Range: $1.63 | 4.54% Avg Daily Range (30 D): $4.06 | 4.52% Avg Daily Range (90 D): $2.63 | 3.92% Institutional Daily Volume Avg Daily Volume: 1.08M Avg Daily Volume (30 D): 1.01M Avg Daily Volume (90 D): .91M Trade Size Avg Trade Size (Sh.): 68 Avg Trade Size (Sh.) (30 D): 46 Avg Trade Size (Sh.) (90 D): 49 Institutional Trades Total Inst.Trades: 659 Avg Inst. Trade: $2.48M Avg Inst. Trade (30 D): $4.04M Avg Inst. Trade (90 D): $3.18M Avg Inst. Trade Volume: .07M Avg Inst. Trades (Per Day): 2 Market Closing Trades Avg Closing Trade: $3.39M Avg Closing Trade (30 D): $6.53M Avg Closing Trade (90 D): $4.69M Avg Closing Volume: 95.45K     News Jul 25, 2025 @ 8:55 AM Minimal Residual Disease Testing Market Trends Ana... Source: Researchandmarkets.Com Apr 22, 2025 @ 4:09 PM Quest Diagnostics Revenue Rebound, Strategic Moves... Source: Vandana Singh Mar 28, 2025 @ 12:37 PM Jim Cramer: Healthpeak Properties Is A 'Reasonable... Source: Avi Kapoor Feb 19, 2025 @ 3:06 PM Investors Eye Biotech Sector as Cancer Therapy Mar... Source: Prnewswire Sep 3, 2024 @ 1:48 PM European Court Rules In Favor Of Illumina In Fight... Source: Vandana Singh Financials   TTM Q3 2025 Q2 2025 Basic EPS $-10.66 $-2.46 Diluted EPS $-10.66 $-2.46 Revenue $ 141.83M $ 36.19M $ Gross Profit $ $ $ Net Income / Loss $ -406.24M $ -88.98M $ -113.99M Operating Income / Loss $ -574.69M $ -125.29M $ Cost of Revenue $ $ $ Net Cash Flow $ -639.74M $ $ PE Ratio